Abstract
In order to provide baseline data on pain and health-related quality of life, to explore factors predicting pain and reduced quality of life, and to find potentially undertreated cases in men with prostate cancer, we undertook a population-based questionnaire study. The questionnaire, which included the EuroQo1 instrument, the Brief Pain Inventory form and 8 specially designed questions, was sent to all men with prostate cancer in the county of Östergötland, Sweden. Of the 1442 men included in the study, 1243 responded to the questionnaire. Altogether 42% had perceived pain during the previous week and 26% stated their quality of life to be 50% or lower on a visual analogue scale. A high rating of health care availability and short time since diagnosis were found to significantly predict lower ratings of pain (P< 0.05). Pain was found to be a significant predictive factor for decreased quality of life together with high age, low rating of health care availability and palliative treatment (P< 0.05). In conclusion, assessment and treatment of pain is essential for a good quality of life in men with prostate cancer. The monitoring of prostate cancer patients should be individualized to fit the demands of the groups with the greatest need for support. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Brooks RG, Jendteg S, Lindgren B, Persson U and Björk S (1991) EuroQol©: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health policy 18: 37–48
Cleary PD, Morrissey G and Oster G (1995) Health-related quality of life in patients with advanced prostate cancer: a multinational perspective. Qual Life Res 4: 207–220
Cleeland CS (1990) Assessment of pain in cancer: measurement issues. Foley KM (ed) Advances in Pain Research and Therapy 16: pp. 47–55, Raven Press: New York
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH and Stewart JA (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330: 592–596
Cleeland CS and Ryan KM (1994) Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med 23: 129–135
Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J and Serlin RC (1996) Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 67: 267–273
Curran D, Fosså S, Aaronson N, Kiebert G, Keuppens F and Hall R (1997) Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG). Eur Journal Cancer 33: 1809–1814
Elliott AM, Smith BH, Penny KI, Smith WC and Chambers WA (1999) The epidemiology of chronic pain in the community. Lancet 354: 1248–1252
EuroQol© Group (1990) EuroQol© – A new facility for measurement of health related quality of life. Health Policy 16: 199–208
Fowler FJ, Barry MJ, Lu Yao G, Wasson J, Roman A and Wennberg J (1995) Effect of radical prostatecomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 45: 1007–1013
Greenwald HP, Bonica JJ and Bergner M (1987) The prevalence of pain in four cancers. Cancer 60: 2563–2569
Helgasson AR, Adolfsson J and Steineck G (1997) Disease specific quality-of-life in men with prostate cancer: a three level epidemiological approach. Journal of Epidemiology and Biostatistics 2: 213–218
Helgesen F, Andersson SO, Gustafsson O, Varenhorst E, Gobén B, Carnock S, Sehlstedt L, Carlsson P, Holmerg L and Johansson JE (2000) Follow-up of Prostate Cancer Patients by On-demand Contacts with a Specialist Nurse. Scand J Urol Nephrol 34: 55–61
Jönler M, Nielsen OS and Wolf H (1998) Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. Urology 52: 1055–1062
Krupski T, Petroni GR, Bissonette EA and Theodorescu D (2000) Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 55: 736–742
Larue F, Colleau SM, Brasseur L and Cleeland CS (1995) Multicentre study of cancer pain and its treatment in France. B Med J 310: 1034–1037
Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC and Carroll PR (1999) Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 53: 180–186
Mandelblatt JS, Yabroff KR and Kerner JF (1999) Equitable access to cancer services: A review of barriers to quality care. Cancer 86: 2387–2390
Mattsson B (1977) The Completeness of Registration in the Swedish Cancer Registry. Stat Rep HS: Stockholm
Pedersen KV, Carlsson P, Rahmquist M and Varenhorst E (1993) Quality of life after radical retropubic prostatectomy for carcinoma of the prostate. Eur Urol 74: 2520–2532
Portenoy RK and Lesage P (1999) Management of pain. Lancet 353: 1695–1700
Rosendahl I, Kiebert GM, Curran D, Cole BF, Weeks JC, Denis LJ and Hall RR (1999) Quality-adjusted survival (QTWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. Prostate 38: 100–109
Sandblom G, Dufmats M, Nordenskjöld K and Varenhorst E (2000) Prostate cancer trends in three counties in Sweden 1987–1996. Results from a population-based register. Cancer 88: 1445–1453
Serlin RC, Mendoza TR, Nakamura Y, Edwards KR and Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61: 277–284
Smith DS, Carvalhal GF, Schneider K, Krygiel J, Yan Y and Catalona WJ (2000) Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer 88: 1454–1463
Van Agt HME, Essink-Bot ML, Krabbe PFM and Bonsel GJ (1994) Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med 39: 1537–1544
Wang XS, Cleeland CS, Mendoza TR, Engstrom MC, Liu S, Xu G, Hao X, Wang Y and Ren XS (1999) The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer 86: 1848–1855
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sandblom, G., Carlsson, P., Sigsjö, P. et al. Pain and health-related quality of life in a geographically defined population of men with prostate cancer. Br J Cancer 85, 497–503 (2001). https://doi.org/10.1054/bjoc.2001.1965
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1965
Keywords
This article is cited by
-
Prevalence of pain 6 months after surgery: a prospective observational study
BMC Anesthesiology (2016)
-
Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials
Quality of Life Research (2013)
-
A population-based study of pain and quality of life during the year before death in men with prostate cancer
British Journal of Cancer (2004)
-
Effects of docetaxel on pain due to metastatic androgen-independent prostate cancer
Current Urology Reports (2002)
